Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
Clinical trial NCT00780416 · COMPLETED
Trial details
- NCT number
- NCT00780416
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-08-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.